ES8502863A1 - Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. - Google Patents

Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.

Info

Publication number
ES8502863A1
ES8502863A1 ES525492A ES525492A ES8502863A1 ES 8502863 A1 ES8502863 A1 ES 8502863A1 ES 525492 A ES525492 A ES 525492A ES 525492 A ES525492 A ES 525492A ES 8502863 A1 ES8502863 A1 ES 8502863A1
Authority
ES
Spain
Prior art keywords
lactam antibiotics
pharmaceutical compositions
compositions containing
containing beta
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525492A
Other languages
English (en)
Other versions
ES525492A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8502863A1 publication Critical patent/ES8502863A1/es
Publication of ES525492A0 publication Critical patent/ES525492A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UN RECIPIENTE HERMETICAMENTE CERRADO QUE CONTIENE AL MENOS UN ANTIBIOTICO DE BETA-LACTAMA.COMPRENDE CARGAR UN ANTIBIOTICO, COMO CEFTAZIMIDA, Y UNA BASE, COMO UN CARBONATO, EN EL RECIPIENTE; DEJAR UN ESPACIO SUPERIOR POR ENCIMA DEL ANTIBIOTICO Y LA BASE, ESTANDO PROVISTO EL ESPACIO SUPERIOR DE UNA ATMOSFERA QUE CONTIENE EL 10 EN VOLUMEN DE UNA CANTIDAD ESTABILIZANTE DE DIOXIDO DE CARBONO A UNA CONCENTRACION MAYOR QUE LA DEL AIRE ATMOSFERICO; Y CERRAR HERMETICAMENTE EL RECIPIENTE COMO PUEDE SER UNA AMPOLLA PARA INYECCION VIAL QUE CONTIENE DE 0,9 A 4 EQUIVALENTES DE BASE A UN EQUIVALENTE ANTIBIOTICO.
ES525492A 1982-09-10 1983-09-08 Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. Granted ES525492A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225853 1982-09-10

Publications (2)

Publication Number Publication Date
ES8502863A1 true ES8502863A1 (es) 1985-02-01
ES525492A0 ES525492A0 (es) 1985-02-01

Family

ID=10532830

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525492A Granted ES525492A0 (es) 1982-09-10 1983-09-08 Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.

Country Status (20)

Country Link
US (2) US4582830A (es)
JP (1) JPS5973518A (es)
KR (1) KR880001094B1 (es)
AT (1) AT388671B (es)
AU (1) AU566245B2 (es)
BE (1) BE897721A (es)
CA (1) CA1215647A (es)
CH (1) CH655008A5 (es)
DE (1) DE3332616C2 (es)
DK (1) DK161304C (es)
ES (1) ES525492A0 (es)
FR (1) FR2532849B1 (es)
GB (1) GB2126479B (es)
IE (1) IE55720B1 (es)
IT (1) IT1197708B (es)
NL (1) NL189948C (es)
NZ (1) NZ205539A (es)
PT (1) PT77323B (es)
SE (1) SE464615B (es)
ZA (1) ZA836703B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
KR890701104A (ko) * 1987-05-27 1989-12-19 에지.지.제이.베르미렌, 에이.디.도우마 β-락탐 항생제의 급용해성 무수 조성물
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
EP0797974B1 (en) * 1994-12-08 2000-08-30 Otsuka Pharmaceutical Factory, Inc. Method of suppressing adsorption of substances derived from container material on drugs
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
ES2686898T3 (es) 2003-04-28 2018-10-22 Takeda Pharmaceutical Company Limited Composición para inyección
JP4700291B2 (ja) * 2003-04-28 2011-06-15 武田薬品工業株式会社 注射用組成物
EP1625859A1 (en) * 2004-08-13 2006-02-15 Access Group ApS A process for the preparation of a package comprising a sterilised bulk of a substance, and a package comprising a sterilised bulk of a penicilin
CN102920710B (zh) * 2012-11-16 2014-05-28 罗诚 一种头孢地嗪化合物的药物组合物
CN103432137B (zh) * 2013-08-28 2015-01-28 芦红代 头孢西丁的药物组合物
CN113350511B (zh) * 2021-03-01 2024-01-02 郎俊娜 一种新型注射用无菌粉末灌装混合保护气

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB737242A (en) * 1952-10-16 1955-09-21 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB760087A (en) * 1952-10-16 1956-10-31 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions
AT307616B (de) * 1969-05-02 1973-05-25 Biochemie Gmbh Verfahren zur Herstellung einer Brausezubereitung
GB1380741A (en) * 1971-02-05 1975-01-15 Squibb & Sons Inc Antibiotic compositions and their preparation
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
LU65921A1 (es) * 1972-08-18 1974-02-21
US4160829A (en) * 1972-12-22 1979-07-10 Gist-Brocades N.V. Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
CA1051780A (en) * 1975-04-09 1979-04-03 Bahram Farhadieh Stable chelocardin composition
GB1575905A (en) * 1976-04-28 1980-10-01 Glaxo Lab Ltd Salt of cefuroxime
GB1504767A (en) * 1976-08-23 1978-03-22 Beecham Group Ltd Antibiotic compositions
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
IT1109207B (it) * 1977-10-10 1985-12-16 Glaxo Group Ltd Composti b-lattamici composizioni antibiotiche che li contengono e procedimento per prepararli
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic

Also Published As

Publication number Publication date
GB8324133D0 (en) 1983-10-12
FR2532849A1 (fr) 1984-03-16
PT77323A (en) 1983-10-01
AU1897583A (en) 1984-03-15
SE464615B (sv) 1991-05-27
IT8348950A0 (it) 1983-09-09
DK409183A (da) 1984-03-11
AT388671B (de) 1989-08-10
GB2126479A (en) 1984-03-28
NL189948B (nl) 1993-04-16
ZA836703B (en) 1984-10-31
PT77323B (en) 1986-02-06
DK161304C (da) 1991-12-02
KR880001094B1 (ko) 1988-06-29
DK409183D0 (da) 1983-09-09
CA1215647A (en) 1986-12-23
CH655008A5 (de) 1986-03-27
NL8303125A (nl) 1984-04-02
AU566245B2 (en) 1987-10-15
KR840006126A (ko) 1984-11-22
NL189948C (nl) 1993-09-16
DE3332616A1 (de) 1984-03-15
US4803196A (en) 1989-02-07
NZ205539A (en) 1986-03-14
US4582830A (en) 1986-04-15
IE55720B1 (en) 1991-01-02
DK161304B (da) 1991-06-24
IE832118L (en) 1984-03-10
ATA322783A (de) 1989-01-15
BE897721A (fr) 1984-03-09
JPH0480883B2 (es) 1992-12-21
GB2126479B (en) 1986-04-03
DE3332616C2 (de) 1995-06-01
SE8304857L (sv) 1984-03-11
IT1197708B (it) 1988-12-06
FR2532849B1 (fr) 1986-08-22
ES525492A0 (es) 1985-02-01
SE8304857D0 (sv) 1983-09-09
JPS5973518A (ja) 1984-04-25

Similar Documents

Publication Publication Date Title
ES8502863A1 (es) Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
ES8500064A1 (es) Un metodo de esterilizar superficies, especialmente superficies de utiles empleados comunmente en medicina
EP0206726A3 (en) Periodontal osseous defect repair
MY114125A (en) Compositions for inhalation
EP0543521A3 (en) High dosage topical forms of collagenase
NZ218612A (en) Composition of ht-pa with argininium ion containing buffer
DE3067351D1 (en) Dentifrice with high foaming ability
DK0630192T3 (da) Psyllium-drikkeblandingsprodukter indeholdende granuleret base
ATE265490T1 (de) Zusammensetzung enthaltend feine feststoffteilchen
TW348063B (en) A pharmaceutical composition in the form of plaster containing pranoprofen
JO1337B1 (en) Pharmaceutical compounds
AU525695B2 (en) Pharmaceutical formulations of prostacyclin
GR3002825T3 (en) Pharmaceutical composition consisting of a calcium carbonate suspension
ES8405636A1 (es) Un metodo de disminuir la concentracion de cloro en una mezcla gaseosa.
AU7878681A (en) Cephalosporin antibiotics and their oxygen, nitrogen and carbon analogues
GB1035005A (en) Local anesthetic preparations and process of making same
EP0162622A3 (en) Gas sensor such as for carbon dioxide in the presence ofgas sensor such as for carbon dioxide in the presence of oxygen oxygen
EP0316189A3 (en) Ir-radiation source and method for producing same
JPS6463342A (en) Stabilization of glutathione-containing composition
ES2033501T3 (es) Procedimiento para la preparacion de polisulfuros de sodio inferiores a partir de polisulfuros de sodio superiores y sodio.
ES2059387T3 (es) Concentrado de estabilizante mejorado.
ATE33552T1 (de) Dermatologische praeparate.
SU1125965A1 (ru) Трехкомпонентная фторидная солевая смесь
AU494778B2 (en) Determining the concentration of gaseous components ina mixture of gases
TH25325A (th) ส่วนผสมของแก๊สเกี่ยวกับการแพทย์